Skip to main content
. 2016 Jan 11;18:3. doi: 10.1186/s12968-015-0222-1

Fig. 1.

Fig. 1

Decision tree and outcome in the study population – CMR + CXA strategy. Diagnostic pathway, treatment, and outcomes are shown for the CMR + CXA strategy in the 3’647 patients of the European CMR Registry. nf-MI: non-fatal MI; ab SCD: aborted SCD